SARS-CoV-2 infection rescues B and T ... - Lung Conditions C...

Lung Conditions Community Forum

56,061 members66,695 posts

SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine.

2greys profile image
2 Replies

A single dose of vaccine boosts protection against SARS-CoV-2 coronavirus variants, but only in those with previous COVID-19, a study has found.

In those who have not previously been infected and have so far only received one dose of vaccine the immune response to variants of concern may be insufficient.

The findings, published today in the journal Science and led by researchers at Imperial College London, Queen Mary University of London and University College London, looked at immune responses in UK healthcare workers at Barts and Royal Free hospitals following their first dose of the Pfizer/BioNTech vaccine.*

They found that people who had previously had mild or asymptomatic infection had significantly enhanced protection against the Kent and South Africa variants, after a single dose of the mRNA vaccine. In those without prior COVID-19, the immune response was less strong after a first dose, potentially leaving them at risk from variants.

imperial.ac.uk/news/220613/...

Sciencemag. Research Paper:

science.sciencemag.org/cont...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Walkwalkwalk profile image
Walkwalkwalk

Hi 2greys. Thanks for these. It’s going to be interesting to see if second doses bring the response of the naive participants to that of pre-infected. The fact that transmission is reduced is important but the immune response will influence how safe vulnerable people will be in the non lockdown stage. Grace

teenieleek profile image
teenieleek

Interesting, glad I was careful until after my second dose. In fact I’m still being careful but I am going to shops now.

Not what you're looking for?

You may also like...

Immunological memory after SARS-CoV-2 infection recovery. *The welcome news we have been waiting for*

Until now, it was unclear whether a survived SARS-CoV-2 infection or COVID-19 leads to a persistent...

Singapore scientists uncover SARS-CoV-2-specific T cell immunity.

A Singapore study has uncovered the presence of virus-specific T cell immunity in people who...

Oxford vaccine stimulates broad antibody and T cell functions.

Today, researchers from the University of Oxford have published further data from the Phase I/II...

‘Mini-lungs’ reveal early stages of SARS-CoV-2 infection

‘Mini-lungs’ grown from tissue donated to Cambridge hospitals has provided a team of scientists...

Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2.

The preliminary data, which have yet to be to peer-reviewed and relate to only a small number of...